The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

13 reports and counting

Updated daily with latest market intelligence
Fundraising
Vor Biopharma

Vor Biopharma Raises $110M in Series C

Vor Biopharma, a Biotech company based in 200 Sidney Street, Cambridge, MA 02139, has raised $110M in Series C at a $700M valuation led by 5AM Ventures, Fidelity, SR One, Novartis Venture Fund, Cormorant Asset Management.

Fundraising News Team
Aug 22, 2024
2 min read
Biotech
Vor Biopharma

Vor Biopharma raises $110M Series C at $700M valuation

Vor Biopharma raises $110M in Series C at $700M valuation. Engineering hematopoietic stem cells...

Editorial Team
Aug 22, 2024
1 min read$110M
Fundraising
Umoja Biopharma

Umoja Biopharma Raises $100M in Series C

Umoja Biopharma, a HealthTech company based in Seattle, WA, has raised $100M in Series C at a $800M valuation led by DCVC Bio, Double Point Ventures.

Fundraising News Team
Jan 1, 2025
2 min read
HealthTech
Umoja Biopharma

Umoja Biopharma raises $100M Series C at $800M valuation

Umoja Biopharma raises $100M in Series C at $800M valuation. Cell therapy for cancer...

Editorial Team
Jan 1, 2025
1 min read$100M
Financial Services
Biopharma Credit

Biopharma Credit Headquarters - Office Location & Address

Discover Biopharma Credit's headquarters at 48 Pall Mall, London, SW1Y 5JG. Pharmaceutical credit investments. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
2 min read
HealthTech
Caidya

Caidya raises $165M Growth

Caidya raises $165M in Growth. Clinical research organization offering biopharma clinical trial services...

Editorial Team
Aug 6, 2025
1 min read$165M
HealthTech
Dianthus Therapeutics

Dianthus Therapeutics raises $288M Public Offering

Dianthus Therapeutics raises $288M in Public Offering. Biopharma developing therapies for autoimmune and inflammatory diseases...

Editorial Team
Sep 9, 2025
1 min read$288M
HealthTech
Mineralys Therapeutics

Mineralys Therapeutics raises $287.5M Public Offering

Mineralys Therapeutics raises $287.5M in Public Offering. Clinical-stage biopharma developing lorundrostat for hypertension treatment...

Editorial Team
Sep 9, 2025
1 min read$287.5M
HealthTech
MapLight Therapeutics

MapLight Therapeutics raises $372.5M Series D

MapLight Therapeutics raises $372.5M in Series D. Biopharma company developing medicines for brain disorders using novel drug discovery platform...

Editorial Team
Sep 29, 2025
1 min read$372.5M
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.